Related Experiment Videos
Multisystemic sarcoidosis associated with a second therapy for chronic hepatitis C
A Froidure1, Y Horsmans, C Lefebvre
1Department of General Internal Medicine, St Luc University Hospital, Brussels, Belgium. a_froidure@hotmail.com
Abstract:
Hepatitis C virus (HCV) infection is a very common chronic infectious disease. Combined antiviral therapy including pegylated interferon and ribavirine is presently the standard treatment, with sustained viral response rate over 50%. Interferon induces the development of several autoimmune diseases. Some cases of induced sarcoidosis have been described (affecting mostly lungs, skin and eyes), both with standard and pegylated interferon. We report the case of an African woman, heterozygote for sickle cell anaemia mutation and for glucose-6-phosphate-deshydrogenase (G6PD) deficiency, who developed a multisystemic sarcoidosis (skin, lungs, liver, salivary and lachrymal glands, peripheral nerves), confirmed by biopsies, in the course of a second treatment with pegylated interferon and ribavirine for hepatitis C. The antiviral treatment was discontinued and all symptoms regressed spontaneously within some weeks.
Related Concept Videos
Cirrhosis II: Pathophysiology
Chronic Pancreatitis II: Collaborative Care
Assessment:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Nephrotic Syndrome II : Assessment and Medical Management
Hepatitis
Cirrhosis I: Introduction